<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04057248</url>
  </required_header>
  <id_info>
    <org_study_id>CP-0010</org_study_id>
    <nct_id>NCT04057248</nct_id>
  </id_info>
  <brief_title>Digital Self-Management and Health Coaching for Type 2 Diabetes - Impact on Diabetes Clinical and Wellness Indicators</brief_title>
  <official_title>Digital Self-Management and Health Coaching for Type 2 Diabetes - Impact on Diabetes Clinical and Wellness Indicators</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LabStyle Innovations Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LabStyle Innovations Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Each subject enrolled in the study will be requested to complete an intake questionnaire&#xD;
      including diabetes quality of life questions. The subject will use Dario Blood glucose&#xD;
      monitoring system and will be contacted by a Certified Diabetes Educator (CDE) two to three&#xD;
      times a month as well as have a direct communication using other communication channels such&#xD;
      as mail, chat and text messaging (SMS) for lifestyle and diabetes management coaching for a&#xD;
      total duration of three months. In the end of study, the subject will complete a diabetes&#xD;
      quality of life questionnaire and have a blood test to evaluate its clinical parameters.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed to assess the effect of digital self-monitoring platform used with the&#xD;
      remote support of a Health coach on clinical outcomes and Diabetes quality of life.&#xD;
&#xD;
      Study design will be an open-label randomized trial of adults with Type 2. Patients are&#xD;
      recruited through the Diabetes and Endocrinology Consultants center setting. Upon&#xD;
      randomization to the intervention group, study participants will receive three months&#xD;
      diabetes health coaching comprising of:&#xD;
&#xD;
        1. Two scheduled phone sessions with a Diabetes health coach a month;&#xD;
&#xD;
        2. Ongoing dual communication with the coach using digital communication channels such as&#xD;
           chat, SMS and emails&#xD;
&#xD;
        3. Diabetes education, behavior modification, goal setting and reinforcement. The Dario App&#xD;
           will record participant's glucose measurements and additional information captured by&#xD;
           the patient such as medication intake, food and physical activity results.&#xD;
&#xD;
      The coach will get access to the patients' App captured information and will intervene ad&#xD;
      necessary in the context of the clinical information.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 9, 2018</start_date>
  <completion_date type="Actual">June 1, 2019</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1C Value at 3 Months From Subject Start of Study Compared to Baseline</measure>
    <time_frame>During 3 Months</time_frame>
    <description>Change of HbA1C taken in blood test 3 month from the subject start of the study.&#xD;
Data was compared to baseline and reporting the HbA1C change from baseline measurement and 3 months after subject start of the clinical study.&#xD;
Measurement was conducted by Quest labs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cholesterol Value at 3 Months From Subject Start of Study</measure>
    <time_frame>During 3 months</time_frame>
    <description>Change of Cholesterol taken in blood test 3 month from the subject start of the study Data was compared to baseline and reporting the Cholesterol change from baseline measurement and 3 months after subject start of the clinical study.&#xD;
Measurement was conducted by Quest labs,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight Value at 3 Months From Subject Start of Study</measure>
    <time_frame>During 3 months</time_frame>
    <description>Change of Weight taken in the clinic at the beginning of the study and 3 month from the subject start of the study Data was compared to baseline and reporting the weight change from baseline measurement and 3 months after subject start of the clinical study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides Value at 3 Months From Subject Start of Study</measure>
    <time_frame>During 3 months</time_frame>
    <description>Change of Triglycerides taken in blood test 3 month from the subject start of the study Data was compared to baseline and reporting the Triglycerides change from baseline measurement and 3 months after subject start of the clinical study.&#xD;
Measurement was conducted by Quest labs,</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Digital platform and CDE coaching intervention for patients with type 2 Diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients provided with digital platform and connected devices. They undergo digital and human (CDE) intervention based on patient captured clinical data.&#xD;
Clinical parameters (HbA1C, weight, lipids profile, etc.) before and after intervention is assessed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dario Blood Glucose Monitoring System</intervention_name>
    <description>Dario Blood Glucose Monitoring System (BGMS) with Dario App and Dario digital platform</description>
    <arm_group_label>Digital platform and CDE coaching intervention for patients with type 2 Diabetes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CDE</intervention_name>
    <description>Certified Diabetes Educator Sessions</description>
    <arm_group_label>Digital platform and CDE coaching intervention for patients with type 2 Diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        To be eligible to participate in this study, a subject must meet all the following&#xD;
        criteria:&#xD;
&#xD;
          1. Adults 35 years of age or older&#xD;
&#xD;
          2. Diagnosed type 2 Diabetes&#xD;
&#xD;
          3. HbA1C test taken less than 2 months ago and is equal to or above 8.5%&#xD;
&#xD;
          4. Able to read, write and understand English&#xD;
&#xD;
          5. Have supported smartphone (see appendix C for the full smartphone list) with internet&#xD;
             package for their service provider&#xD;
&#xD;
          6. The subject is able and agrees to sign the informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Adults with impaired cognition&#xD;
&#xD;
          2. Cohabiting with a participant in the study&#xD;
&#xD;
          3. Have an underlying medical condition (such as kidney disease, hemoglobin variants,&#xD;
             anemia) that may provide misleading A1C levels&#xD;
&#xD;
          4. Subject is critically ill&#xD;
&#xD;
          5. Subject has an impairment that prevents him/her from following the study procedures&#xD;
&#xD;
          6. Subject is not using medication that may interfere with the blood glucose measurement&#xD;
&#xD;
          7. HCT level which are outside Dario BGMS declared range (20%-60%)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Schorr, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diabetes and Endocrinology Consultants of Pennsylvania, LLC (Decpa LLC)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diabetes and Endocrinology Consultants of Pennsylvania, LLC (Decpa LLC)</name>
      <address>
        <city>Feasterville</city>
        <state>Pennsylvania</state>
        <zip>19047-1845</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 13, 2019</study_first_submitted>
  <study_first_submitted_qc>August 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2019</study_first_posted>
  <results_first_submitted>February 2, 2021</results_first_submitted>
  <results_first_submitted_qc>March 4, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 30, 2021</results_first_posted>
  <last_update_submitted>May 9, 2021</last_update_submitted>
  <last_update_submitted_qc>May 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 9, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/48/NCT04057248/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>No significant events occurred after study participant enrollment. 2 people were inactive.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Individual's Quality of Life and Clinical Parameters</title>
          <description>Clinical parameters (HbA1C, weight, lipids profile, etc.)&#xD;
Dario Blood Glucose Monitoring System: Dario Blood Glucose Monitoring System (BGMS) with Dario App and Dario digital platform&#xD;
CDE: Certified Diabetes Educator Sessions</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Individual's Quality of Life and Clinical Parameters</title>
          <description>Clinical parameters (HbA1C, weight, lipids profile, etc.)&#xD;
Dario Blood Glucose Monitoring System: Dario Blood Glucose Monitoring System (BGMS) with Dario App and Dario digital platform&#xD;
CDE: Certified Diabetes Educator Sessions</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.4" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HBA1C&gt;8.5</title>
          <population>2 participants were inactive during the study</population>
          <units>percentage of HBA1C in blood</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.2" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <population>2 participants were inactive during the study</population>
          <units>lbs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="233.9" spread="59.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total Cholesterol</title>
          <population>2 participants were inactive during the study</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="180.3" spread="53.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Triglycerides value</title>
          <population>2 participants were inactive during the study</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="192.5" spread="113.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>HbA1C Value at 3 Months From Subject Start of Study Compared to Baseline</title>
        <description>Change of HbA1C taken in blood test 3 month from the subject start of the study.&#xD;
Data was compared to baseline and reporting the HbA1C change from baseline measurement and 3 months after subject start of the clinical study.&#xD;
Measurement was conducted by Quest labs.</description>
        <time_frame>During 3 Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Individual's Quality of Life and Clinical Parameters</title>
            <description>Clinical parameters (HbA1C, weight, lipids profile, etc.)&#xD;
Dario Blood Glucose Monitoring System: Dario Blood Glucose Monitoring System (BGMS) with Dario App and Dario digital platform&#xD;
CDE: Certified Diabetes Educator Sessions</description>
          </group>
        </group_list>
        <measure>
          <title>HbA1C Value at 3 Months From Subject Start of Study Compared to Baseline</title>
          <description>Change of HbA1C taken in blood test 3 month from the subject start of the study.&#xD;
Data was compared to baseline and reporting the HbA1C change from baseline measurement and 3 months after subject start of the clinical study.&#xD;
Measurement was conducted by Quest labs.</description>
          <units>percentage of HBA1C in blood</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cholesterol Value at 3 Months From Subject Start of Study</title>
        <description>Change of Cholesterol taken in blood test 3 month from the subject start of the study Data was compared to baseline and reporting the Cholesterol change from baseline measurement and 3 months after subject start of the clinical study.&#xD;
Measurement was conducted by Quest labs,</description>
        <time_frame>During 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Individual's Quality of Life and Clinical Parameters</title>
            <description>Clinical parameters (HbA1C, weight, lipids profile, etc.)&#xD;
Dario Blood Glucose Monitoring System: Dario Blood Glucose Monitoring System (BGMS) with Dario App and Dario digital platform&#xD;
CDE: Certified Diabetes Educator Sessions</description>
          </group>
        </group_list>
        <measure>
          <title>Cholesterol Value at 3 Months From Subject Start of Study</title>
          <description>Change of Cholesterol taken in blood test 3 month from the subject start of the study Data was compared to baseline and reporting the Cholesterol change from baseline measurement and 3 months after subject start of the clinical study.&#xD;
Measurement was conducted by Quest labs,</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="179.0" spread="70.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Weight Value at 3 Months From Subject Start of Study</title>
        <description>Change of Weight taken in the clinic at the beginning of the study and 3 month from the subject start of the study Data was compared to baseline and reporting the weight change from baseline measurement and 3 months after subject start of the clinical study.</description>
        <time_frame>During 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Individual's Quality of Life and Clinical Parameters</title>
            <description>Clinical parameters (HbA1C, weight, lipids profile, etc.)&#xD;
Dario Blood Glucose Monitoring System: Dario Blood Glucose Monitoring System (BGMS) with Dario App and Dario digital platform&#xD;
CDE: Certified Diabetes Educator Sessions</description>
          </group>
        </group_list>
        <measure>
          <title>Weight Value at 3 Months From Subject Start of Study</title>
          <description>Change of Weight taken in the clinic at the beginning of the study and 3 month from the subject start of the study Data was compared to baseline and reporting the weight change from baseline measurement and 3 months after subject start of the clinical study.</description>
          <units>lbs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="230.7" spread="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Triglycerides Value at 3 Months From Subject Start of Study</title>
        <description>Change of Triglycerides taken in blood test 3 month from the subject start of the study Data was compared to baseline and reporting the Triglycerides change from baseline measurement and 3 months after subject start of the clinical study.&#xD;
Measurement was conducted by Quest labs,</description>
        <time_frame>During 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Individual's Quality of Life and Clinical Parameters</title>
            <description>Clinical parameters (HbA1C, weight, lipids profile, etc.)&#xD;
Dario Blood Glucose Monitoring System: Dario Blood Glucose Monitoring System (BGMS) with Dario App and Dario digital platform&#xD;
CDE: Certified Diabetes Educator Sessions</description>
          </group>
        </group_list>
        <measure>
          <title>Triglycerides Value at 3 Months From Subject Start of Study</title>
          <description>Change of Triglycerides taken in blood test 3 month from the subject start of the study Data was compared to baseline and reporting the Triglycerides change from baseline measurement and 3 months after subject start of the clinical study.&#xD;
Measurement was conducted by Quest labs,</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="172.0" spread="121.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>9 months</time_frame>
      <desc>Reporting requirements are provided in compliance with 21 CFR 812.150(b) (1).&#xD;
All-Cause Mortality: No mortalities were recorded during the study Serious Adverse Events: No serious adverse events were recorded during the study Other (Not Including Serious) Adverse Events: No other adverse events were recorded during the study</desc>
      <group_list>
        <group group_id="E1">
          <title>Individual's Quality of Life and Clinical Parameters</title>
          <description>Clinical parameters (HbA1C, weight, lipids profile, etc.)&#xD;
Dario Blood Glucose Monitoring System: Dario Blood Glucose Monitoring System (BGMS) with Dario App and Dario digital platform&#xD;
CDE: Certified Diabetes Educator Sessions</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Alan Schorr</name_or_title>
      <organization>Diabetes and Endocrinology Consultants of Pennsylvania, LLC (Decpa LLC)</organization>
      <phone>2157501691</phone>
      <email>abs@sugardoc.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

